No Data
No Data
Semler Scientific, Genetic Technologies, ReShape Lifesciences Among Healthcare Movers
Genetic Technologies Releases Risk Assessment Test for Breast, Ovarian Cancer; Shares Jump 14%
Genetic Technologies (ASX:GTG) launched its novel geneType risk assessment test for breast and ovarian cancer, the molecular diagnostics company said in a Wednesday filing with the Australian Securiti
Genetic Technologies Unveils Pioneering Cancer Test
Genetic Technologies Plans U.S. Securities Offering
Genetic Technologies Forges Major US Wellness Partnership
Genetic Technologies And Wellworks For You Sign B2b Sales & Marketing Deal Covering 750 Employer Groups And 2M U.S. Employees
Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, ", Company", , ", GTG", )), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce the execution
No Data